Tecnología en Endocrinología: tiempos, conceptos e implementación

Hughes TP. History of technology. En: International Encyclopedia of the Social & Behavioral Sciences. Elsevier; 2001;6852–7. https://doi.org/10.1016/B0-08-043076-7/02648-6

Real Academia Española: Diccionario de la lengua española, 23.ª ed., [versión 23.4 en línea]. <https://dle.rae.es> [citado el 22 jul 2021].

Díaz-Caballero JR. Notas sobre el origen del hombre y la ciencia. En: Grupo de Estudios Sociales de la Tecnología. Tecnología y Sociedad. 1999:3–10.

Reflexión Editorial de Zarate-Triviño.

Scharff RC, Dusek V. Philosophy of Technology: The Technological Condition: An Anthology. 2a ed. Hoboken, NJ, Estados Unidos de América: Wiley-Blackwell; 2014. 736 p.

Bunge M. Epistemología: Curso de actualización. 3a ed. Siglo XXI Ediciones; 2002.

The Croonian lectures on the chemical correlation of the functions of the body: delivered before the Royal College of Physicians of London on June 20th, 22nd, 27th & 29th, 1905 / by Ernest Henry Starling [Internet]. Wellcomecollection.org. [citado 12 jul 2021]. Disponible en: https://wellcomecollection.org/works/rd4gsvmp

Brush SG, Nettie M. Stevens and the discovery of sex determination by chromosomes. Isis. 1978;69(2):163–-72. https://doi.org/10.1086/352001

Yalow RS, Berson SA. Immunoassay of endogenous plasma insulin in man. J Clin Invest. 1960;39(7):1157–75. https://doi.org/10.1172/JCI104130

Cusano NE, Silverberg SJ, Bilezikian JP. Normocalcemic primary hyperparathyroidism. J Clin Densitom. 2013;16(1):33–9. https://doi.org/10.1016/j.jocd.2012.12.001

Wermers RA, Khosla S, Atkinson EJ, Achenbach SJ, Oberg AL, Grant CS, et al. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease. J Bone Miner Res. 2006;21(1):171–7. https://doi.org/10.1359/JBMR.050910

Means JH. Historical background of the use of radioactive Iodine in medicine. N Engl J Med. 1955;252(22):936–40. https://doi.org/10.1056/NEJM195506022522204

Joliot F, Curie I. Artificial production of a new kind of radio-element. Nature. 1934;133(3354):201–2. https://doi.org/10.1038/133201a0

Fermi E. Radioactivity induced by neutron bombardment. Nature. 1934;133(3368):757. https://doi.org/10.1038/133757a0

Hertz S, Roberts A, Evans RD. Radioactive iodine as an indicator in the study of thyroid physiology. Exp Biol Med (Maywood). 1938;38(4):510–3. https://doi.org/10.3181/00379727-38-9915P

Hertz S, Roberts A. Radioactive iodine in the study of thyroid physiology; the use of radioactive iodine therapy in hyperthyroidism. J Am Med Assoc. 1946;131:81–6. https://doi.org/10.1001/jama.1946.02870190005002

Chapman EM, Evans RD. The treatment of hyperthyroidism with radioactive iodine. J Am Med Assoc. 1946;131(2):86–91. https://doi.org/10.1001/jama.1946.02870190010003

Keston AS, Ball RP, Frantz VK, Palmer WW. Storage of radioactive iodine in a metastasis from thyroid carcinoma. Science. 1942;95(2466):362–3. https://doi.org/10.1126/science.95.2466.362

Heintzman ND. A digital ecosystem of diabetes data and technology: Services, systems, and tools enabled by wearables, sensors, and apps. J Diabetes Sci Technol. 2015;10(1):35–41. https://doi.org/10.1177/1932296815622453

Tauschmann M, Hovorka R. Technology in the management of type 1 diabetes mellitus - current status and future prospects. Nat Rev Endocrinol. 2018;14(8):464–75. https://doi.org/10.1038/s41574-018-0044-y

Paton JS, Wilson M, Ireland JT, Reith SB. Convenient pocket insulin syringe. Lancet (Londres, Inglaterra) 1981;1(8213):189–190. https://doi.org/10.1016/S0140-6736(81)90063-5

Renard E. Insulin pump use in Europe. Diabetes Technol Ther. 2010;12 Suppl 1(S1): S29–32. https://doi.org/10.1089/dia.2009.0189

Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW.10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes. N Engl J Med. 2008;359(15):1577–89. https://doi.org/10.1056/NEJMoa0806470

Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: The DCCT/EDIC study 30-year follow-up. Diabetes Care. 2016;39(5):686–93. https://doi.org/10.2337/dc15-1990

Bailey T, Bode BW, Christiansen MP, Klaff LJ, Alva S. The performance and usability of a factory-calibrated flash glucose monitoring system. Diabetes Technol Ther. 2015;17(11): 787–94. https://doi.org/10.1089/dia.2014.0378

Bergenstal RM. Continuous glucose monitoring: transforming diabetes management step by step. Lancet. 2018;391(10128):1334–36. https://doi.org/10.1016/S0140-6736(18)30290-3

Bergenstal RM, Klonoff DC, Garg SK, Bode BW, Meredith M, Slover RH, et al. Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med. 2013;369(3):224–32. https://doi.org/10.1056/NEJMoa1303576

Battelino T, Nimri R, Dovc K, Phillip M, Bratina N. Prevention of hypoglycemia with predictive low glucose insulin suspension in children with type 1 diabetes: a randomized controlled trial. Diabetes Care. 2017;40(6):764–70. https://doi.org/10.2337/dc16-2584

Garg SK, Weinzimer SA, Tamborlane WV, Buckingham BA, Bode BW, Bailey Ts, et al. Glucose Outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes. Diabetes Technol Ther. 2017;19(3):155–63. https://doi.org/10.1089/dia.2016.0421

Duke DC, Barry S, Wagner DV, Speight J, Choudhary P, Harris MA. Distal technologies and type 1 diabetes management. Lancet Diabetes Endocrinol. 2018;6(2):143–56. https://doi.org/10.1016/S2213-8587(17)30260-7

Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kröger J, Weitgasser R. Novel glucose-sensing technology and hypoglycemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. [Nueva tecnología de sensores de glucosa e hipoglucemia en diabetes tipo 1: un ensayo multicéntrico, controlado y aleatorizado, no enmascarado]. Lancet. 2016;388(10057):2254–63. https://doi.org/10.1016/S0140-6736(16)31535-5

Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline J-P, Rayman G. Use of flash glucose-sensing technology for 12 months as a replacement for blood glucose monitoring in insulin-treated type 2 diabetes. [Tecnología Flash de sensores de glucosa en sustitución de la monitorización de glucemia para el manejo de la diabetes tipo 2 en tratamiento con insulina: ensayo controlado, aleatorizado, abierto y multicéntrico]. Diabetes Ther. 2017;8(3):573–86. https://doi.org/10.1007/s13300-017-0255-6

Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biestel T, et al. Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the international consensus on time in range. Diabetes Care. 2019;42(8):1593–1603. https://doi.org/10.2337/dci19-0028

Trawley S, Browne JL, Hagger VL, Hendrieckx C, Holmes-Truscott E, Pouwer F, et al. The use of mobile applications among adolescents with type 1 diabetes: Results from Diabetes MILES Youth-Australia. Diabetes Technol Ther. 2016;18(12),813–9. https://doi.org/10.1089/dia.2016.0233

Hughes TP. History of technology. En: International Encyclopedia of the Social & Behavioral Sciences. Elsevier; 2001;6852–7. https://doi.org/10.1016/B0-08-043076-7/02648-6

Real Academia Española: Diccionario de la lengua española, 23.ª ed., [versión 23.4 en línea]. <https://dle.rae.es> [citado el 22 jul 2021].

Díaz-Caballero JR. Notas sobre el origen del hombre y la ciencia. En: Grupo de Estudios Sociales de la Tecnología. Tecnología y Sociedad. 1999:3–10.

Reflexión Editorial de Zarate-Triviño.

Scharff RC, Dusek V. Philosophy of Technology: The Technological Condition: An Anthology. 2a ed. Hoboken, NJ, Estados Unidos de América: Wiley-Blackwell; 2014. 736 p.

Bunge M. Epistemología: Curso de actualización. 3a ed. Siglo XXI Ediciones; 2002.

The Croonian lectures on the chemical correlation of the functions of the body: delivered before the Royal College of Physicians of London on June 20th, 22nd, 27th & 29th, 1905 / by Ernest Henry Starling [Internet]. Wellcomecollection.org. [citado 12 jul 2021]. Disponible en: https://wellcomecollection.org/works/rd4gsvmp

Brush SG, Nettie M. Stevens and the discovery of sex determination by chromosomes. Isis. 1978;69(2):163–-72. https://doi.org/10.1086/352001

Yalow RS, Berson SA. Immunoassay of endogenous plasma insulin in man. J Clin Invest. 1960;39(7):1157–75. https://doi.org/10.1172/JCI104130

Cusano NE, Silverberg SJ, Bilezikian JP. Normocalcemic primary hyperparathyroidism. J Clin Densitom. 2013;16(1):33–9. https://doi.org/10.1016/j.jocd.2012.12.001

Wermers RA, Khosla S, Atkinson EJ, Achenbach SJ, Oberg AL, Grant CS, et al. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease. J Bone Miner Res. 2006;21(1):171–7. https://doi.org/10.1359/JBMR.050910

Means JH. Historical background of the use of radioactive Iodine in medicine. N Engl J Med. 1955;252(22):936–40. https://doi.org/10.1056/NEJM195506022522204

Joliot F, Curie I. Artificial production of a new kind of radio-element. Nature. 1934;133(3354):201–2. https://doi.org/10.1038/133201a0

Fermi E. Radioactivity induced by neutron bombardment. Nature. 1934;133(3368):757. https://doi.org/10.1038/133757a0

Hertz S, Roberts A, Evans RD. Radioactive iodine as an indicator in the study of thyroid physiology. Exp Biol Med (Maywood). 1938;38(4):510–3. https://doi.org/10.3181/00379727-38-9915P

Hertz S, Roberts A. Radioactive iodine in the study of thyroid physiology; the use of radioactive iodine therapy in hyperthyroidism. J Am Med Assoc. 1946;131:81–6. https://doi.org/10.1001/jama.1946.02870190005002

Chapman EM, Evans RD. The treatment of hyperthyroidism with radioactive iodine. J Am Med Assoc. 1946;131(2):86–91. https://doi.org/10.1001/jama.1946.02870190010003

Keston AS, Ball RP, Frantz VK, Palmer WW. Storage of radioactive iodine in a metastasis from thyroid carcinoma. Science. 1942;95(2466):362–3. https://doi.org/10.1126/science.95.2466.362

Heintzman ND. A digital ecosystem of diabetes data and technology: Services, systems, and tools enabled by wearables, sensors, and apps. J Diabetes Sci Technol. 2015;10(1):35–41. https://doi.org/10.1177/1932296815622453

Tauschmann M, Hovorka R. Technology in the management of type 1 diabetes mellitus - current status and future prospects. Nat Rev Endocrinol. 2018;14(8):464–75. https://doi.org/10.1038/s41574-018-0044-y

Paton JS, Wilson M, Ireland JT, Reith SB. Convenient pocket insulin syringe. Lancet (Londres, Inglaterra) 1981;1(8213):189–190. https://doi.org/10.1016/S0140-6736(81)90063-5

Renard E. Insulin pump use in Europe. Diabetes Technol Ther. 2010;12 Suppl 1(S1): S29–32. https://doi.org/10.1089/dia.2009.0189

Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW.10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes. N Engl J Med. 2008;359(15):1577–89. https://doi.org/10.1056/NEJMoa0806470

Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: The DCCT/EDIC study 30-year follow-up. Diabetes Care. 2016;39(5):686–93. https://doi.org/10.2337/dc15-1990

Bailey T, Bode BW, Christiansen MP, Klaff LJ, Alva S. The performance and usability of a factory-calibrated flash glucose monitoring system. Diabetes Technol Ther. 2015;17(11): 787–94. https://doi.org/10.1089/dia.2014.0378

Bergenstal RM. Continuous glucose monitoring: transforming diabetes management step by step. Lancet. 2018;391(10128):1334–36. https://doi.org/10.1016/S0140-6736(18)30290-3

Bergenstal RM, Klonoff DC, Garg SK, Bode BW, Meredith M, Slover RH, et al. Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med. 2013;369(3):224–32. https://doi.org/10.1056/NEJMoa1303576

Battelino T, Nimri R, Dovc K, Phillip M, Bratina N. Prevention of hypoglycemia with predictive low glucose insulin suspension in children with type 1 diabetes: a randomized controlled trial. Diabetes Care. 2017;40(6):764–70. https://doi.org/10.2337/dc16-2584

Garg SK, Weinzimer SA, Tamborlane WV, Buckingham BA, Bode BW, Bailey Ts, et al. Glucose Outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes. Diabetes Technol Ther. 2017;19(3):155–63. https://doi.org/10.1089/dia.2016.0421

Duke DC, Barry S, Wagner DV, Speight J, Choudhary P, Harris MA. Distal technologies and type 1 diabetes management. Lancet Diabetes Endocrinol. 2018;6(2):143–56. https://doi.org/10.1016/S2213-8587(17)30260-7

Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kröger J, Weitgasser R. Novel glucose-sensing technology and hypoglycemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. [Nueva tecnología de sensores de glucosa e hipoglucemia en diabetes tipo 1: un ensayo multicéntrico, controlado y aleatorizado, no enmascarado]. Lancet. 2016;388(10057):2254–63. https://doi.org/10.1016/S0140-6736(16)31535-5

Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline J-P, Rayman G. Use of flash glucose-sensing technology for 12 months as a replacement for blood glucose monitoring in insulin-treated type 2 diabetes. [Tecnología Flash de sensores de glucosa en sustitución de la monitorización de glucemia para el manejo de la diabetes tipo 2 en tratamiento con insulina: ensayo controlado, aleatorizado, abierto y multicéntrico]. Diabetes Ther. 2017;8(3):573–86. https://doi.org/10.1007/s13300-017-0255-6

Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biestel T, et al. Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the international consensus on time in range. Diabetes Care. 2019;42(8):1593–1603. https://doi.org/10.2337/dci19-0028

Trawley S, Browne JL, Hagger VL, Hendrieckx C, Holmes-Truscott E, Pouwer F, et al. The use of mobile applications among adolescents with type 1 diabetes: Results from Diabetes MILES Youth-Australia. Diabetes Technol Ther. 2016;18(12),813–9. https://doi.org/10.1089/dia.2016.0233

acromegalia
arte
bocio
cerámica
cuarzo
cultura
enfermedad de Graves
paleopatología
síndrome de Klinefelter
patología